https://targedbiopharmaceuticals.com/news/targed-closes-e1-35m-seed-investment-round/ 2024-01-25T14:46:02+00:00 https://targedbiopharmaceuticals.com/app/uploads/2020/11/targedbiopharmaceuticals_cover-scaled.jpg https://targedbiopharmaceuticals.com/news/targed-is-granted-the-nwo-take-off-ii-loan/ 2024-01-25T14:47:17+00:00 https://targedbiopharmaceuticals.com/app/uploads/2022/02/Series-A.jpg https://targedbiopharmaceuticals.com/news/appointed-scientific-advisory-board-ais/ 2024-01-29T13:21:03+00:00 https://targedbiopharmaceuticals.com/app/uploads/2022/09/advisory-board.jpeg https://targedbiopharmaceuticals.com/news/targed-raises-e39-million-in-a-series-a-investment-round/ 2024-01-29T13:23:14+00:00 https://targedbiopharmaceuticals.com/app/uploads/2022/02/Series-A.jpg https://targedbiopharmaceuticals.com/news/appointed-erik-van-den-berg-as-chair-of-board/ 2024-01-29T14:56:53+00:00 https://targedbiopharmaceuticals.com/app/uploads/2024/01/Erik-van-den-Berg2.jpg https://targedbiopharmaceuticals.com/news/founded/ 2024-01-29T15:10:30+00:00 https://targedbiopharmaceuticals.com/app/uploads/2020/07/Founders1-scaled.jpg https://targedbiopharmaceuticals.com/news/microlyse-as-treatment-for-ais-published-in-blood-journal/ 2024-01-30T10:38:23+00:00 https://targedbiopharmaceuticals.com/app/uploads/2024/01/blood-e1704899266486.jpg https://targedbiopharmaceuticals.com/news/microlyse-as-treatment-for-ttp-published-in-blood-journal/ 2024-01-31T10:09:03+00:00 https://targedbiopharmaceuticals.com/app/uploads/2024/01/blood-e1704899266486.jpg https://targedbiopharmaceuticals.com/news/key-appointments-management-team/ 2024-02-02T09:34:49+00:00 https://targedbiopharmaceuticals.com/app/uploads/2024/02/MT-team-2-news-scaled.jpg https://targedbiopharmaceuticals.com/news/dr-anja-harmeier-as-supervisory-board-member/ 2024-02-02T14:20:35+00:00 https://targedbiopharmaceuticals.com/app/uploads/2024/02/Anja-Harmeier-news-scaled.jpg https://targedbiopharmaceuticals.com/news/tgd001-receives-orphan-drug-designation-in-europe/ 2024-10-31T04:49:00+00:00 https://targedbiopharmaceuticals.com/news/anne-grethe-mortensen-joins-targed-as-non-executive-board-member/ 2024-11-18T09:51:31+00:00 https://targedbiopharmaceuticals.com/app/uploads/2024/11/Anne-Grethe-Mortensen.jpg https://targedbiopharmaceuticals.com/news/targed-enters-clinic-with-phase-1-trial-of-its-groundbreaking-thrombolytic-tgd001-2/ 2024-12-19T08:31:11+00:00 https://targedbiopharmaceuticals.com/app/uploads/2024/12/Blood-clot-dissolving.png https://targedbiopharmaceuticals.com/news/tgd001-receives-orphan-drug-designation-in-the-united-states-of-america/ 2025-03-24T11:32:03+00:00 https://targedbiopharmaceuticals.com/news/filip-van-den-wyngaert-joins-targed-as-vice-president-asset-management/ 2025-04-28T13:32:26+00:00 https://targedbiopharmaceuticals.com/app/uploads/2025/04/businessportret-0424-3594-scaled.jpg https://targedbiopharmaceuticals.com/news/samuel-white-joins-targed-as-chief-business-officer/ 2025-07-01T09:30:09+00:00 https://targedbiopharmaceuticals.com/app/uploads/2025/07/Samuel-White2-scaled-e1751360671817.jpg https://targedbiopharmaceuticals.com/news/targed-secures-eic-accelerator-grant/ 2025-07-03T15:38:00+00:00 https://targedbiopharmaceuticals.com/news/targed-to-present-first-clinical-and-new-preclinical-data-on-tgd001-at-ash-2025/ 2025-11-03T14:00:22+00:00 https://targedbiopharmaceuticals.com/app/uploads/2025/11/ASH-presentations-.png https://targedbiopharmaceuticals.com/news/targed-presents-positive-clinical-results-for-tgd001-from-phase-1-study-during-oral-session-at-ash-2025/ 2025-12-08T19:46:04+00:00 https://targedbiopharmaceuticals.com/app/uploads/2025/12/TargED_ASH-LinkedIn-Caroussell-Post_1200x1500_FINAL-1.pdf https://targedbiopharmaceuticals.com/news/targed-secures-e21-5-million-series-a-extension-total-funding-now-over-e60-million/ 2025-12-16T13:00:12+00:00 https://targedbiopharmaceuticals.com/app/uploads/2025/12/21.5-Series-A-Extension-1.png https://targedbiopharmaceuticals.com/news/rob-dekker-joins-targed-as-vice-president-cmc/ 2026-03-05T12:41:51+00:00 https://targedbiopharmaceuticals.com/news/targed-secures-40-4-million-series-a2-extension/ 2026-06-24T19:17:07+00:00 https://targedbiopharmaceuticals.com/app/uploads/2026/06/40.4M2.png https://targedbiopharmaceuticals.com/news/first-patients-successfully-dosed-in-tgd001-acute-ischemic-stroke-study/ 2026-07-16T14:23:13+00:00 https://targedbiopharmaceuticals.com/app/uploads/2026/07/First-AIS-patients.png